ENDPOINTS

Analyzing the Endpoints 100; ‘Most favored nation’ targets revealed; Biotech slump makes leases a liability; and more

Welcome back to another edition of Endpoints Weekly. We had another busy week chock-full of news, so let’s jump into the headlines. We kick off this week with founding editor John Carroll’s latest survey of ...

May 24, 2025 - 11:04
 0
Analyzing the Endpoints 100; ‘Most favored nation’ targets revealed; Biotech slump makes leases a liability; and more
Welcome back to another edition of Endpoints Weekly. We had another busy week chock-full of news, so let’s jump into the headlines. We kick off this week with founding editor John Carroll’s latest survey of ...
Read More

Tags:

Previous Article

When will the universe die?

Next Article

James Webb telescope discovers frozen water around a distant, sunlike star

Related Posts

Biotech downturn exposes startups to big lease liabilities

Biotech downturn exposes startups to big lease liabilities

May 21, 2025  0

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notche...

May 16, 2025  0

Stelara biosimilars look to gain traction, helped by recent lessons from Humira

Stelara biosimilars look to gain traction, helped by re...

May 19, 2025  0